A Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 27 Oct 2017
At a glance
- Drugs AZD-1775 (Primary) ; Carboplatin; Paclitaxel
- Indications Lung cancer; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 20 Oct 2017 Planned End Date changed from 1 Mar 2018 to 1 Oct 2019.
- 20 Oct 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Oct 2018.
- 06 Jun 2017 Results of interim analysis (n=15), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology